

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.54189248 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 6.54189248 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.34941290 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 6.34941290 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 6.34921992 |
| 6 | tryptophan catabolic process (GO:0006569) | 6.04561320 |
| 7 | indole-containing compound catabolic process (GO:0042436) | 6.04561320 |
| 8 | indolalkylamine catabolic process (GO:0046218) | 6.04561320 |
| 9 | glyoxylate metabolic process (GO:0046487) | 5.80414352 |
| 10 | tryptophan metabolic process (GO:0006568) | 5.60310080 |
| 11 | kynurenine metabolic process (GO:0070189) | 5.49042581 |
| 12 | lysine metabolic process (GO:0006553) | 5.37561658 |
| 13 | lysine catabolic process (GO:0006554) | 5.37561658 |
| 14 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.29250463 |
| 15 | sulfur amino acid catabolic process (GO:0000098) | 5.28384625 |
| 16 | bile acid biosynthetic process (GO:0006699) | 5.26369736 |
| 17 | cysteine metabolic process (GO:0006534) | 5.23291220 |
| 18 | alpha-linolenic acid metabolic process (GO:0036109) | 5.14360310 |
| 19 | cellular ketone body metabolic process (GO:0046950) | 5.02093561 |
| 20 | plasma lipoprotein particle clearance (GO:0034381) | 4.97207406 |
| 21 | amino-acid betaine metabolic process (GO:0006577) | 4.89510326 |
| 22 | drug transmembrane transport (GO:0006855) | 4.89264066 |
| 23 | regulation of plasminogen activation (GO:0010755) | 4.81309072 |
| 24 | bile acid metabolic process (GO:0008206) | 4.79898895 |
| 25 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.79570134 |
| 26 | serine family amino acid catabolic process (GO:0009071) | 4.72184580 |
| 27 | cellular glucuronidation (GO:0052695) | 4.64461318 |
| 28 | positive regulation of steroid metabolic process (GO:0045940) | 4.54525111 |
| 29 | aromatic amino acid family metabolic process (GO:0009072) | 4.53996699 |
| 30 | homocysteine metabolic process (GO:0050667) | 4.53845922 |
| 31 | bile acid and bile salt transport (GO:0015721) | 4.48194871 |
| 32 | glutamate metabolic process (GO:0006536) | 4.46374159 |
| 33 | regulation of lipoprotein particle clearance (GO:0010984) | 4.43143091 |
| 34 | negative regulation of lipase activity (GO:0060192) | 4.39013124 |
| 35 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.38810294 |
| 36 | protein carboxylation (GO:0018214) | 4.38810294 |
| 37 | negative regulation of sterol transport (GO:0032372) | 4.38764617 |
| 38 | negative regulation of cholesterol transport (GO:0032375) | 4.38764617 |
| 39 | urea metabolic process (GO:0019627) | 4.35879465 |
| 40 | urea cycle (GO:0000050) | 4.35879465 |
| 41 | urate metabolic process (GO:0046415) | 4.34595604 |
| 42 | alpha-amino acid catabolic process (GO:1901606) | 4.33420057 |
| 43 | drug catabolic process (GO:0042737) | 4.32609080 |
| 44 | ketone body metabolic process (GO:1902224) | 4.30981195 |
| 45 | short-chain fatty acid metabolic process (GO:0046459) | 4.29315279 |
| 46 | glucuronate metabolic process (GO:0019585) | 4.28900829 |
| 47 | uronic acid metabolic process (GO:0006063) | 4.28900829 |
| 48 | high-density lipoprotein particle remodeling (GO:0034375) | 4.28842646 |
| 49 | ethanol oxidation (GO:0006069) | 4.23811772 |
| 50 | signal peptide processing (GO:0006465) | 4.22450563 |
| 51 | regulation of triglyceride catabolic process (GO:0010896) | 4.21254353 |
| 52 | maintenance of gastrointestinal epithelium (GO:0030277) | 4.14777723 |
| 53 | cellular amino acid catabolic process (GO:0009063) | 4.14333332 |
| 54 | indolalkylamine metabolic process (GO:0006586) | 4.13972826 |
| 55 | acylglycerol homeostasis (GO:0055090) | 4.12746622 |
| 56 | triglyceride homeostasis (GO:0070328) | 4.12746622 |
| 57 | regulation of response to osmotic stress (GO:0047484) | 4.10361447 |
| 58 | flavonoid metabolic process (GO:0009812) | 4.09567807 |
| 59 | negative regulation of fibrinolysis (GO:0051918) | 4.08175483 |
| 60 | hyperosmotic salinity response (GO:0042538) | 4.07320754 |
| 61 | cellular modified amino acid catabolic process (GO:0042219) | 4.07180960 |
| 62 | amine catabolic process (GO:0009310) | 4.07030584 |
| 63 | cellular biogenic amine catabolic process (GO:0042402) | 4.07030584 |
| 64 | regulation of fibrinolysis (GO:0051917) | 4.05989164 |
| 65 | nitrogen cycle metabolic process (GO:0071941) | 4.04296840 |
| 66 | drug transport (GO:0015893) | 4.02213032 |
| 67 | cell adhesion mediated by integrin (GO:0033627) | 4.02187224 |
| 68 | negative regulation of catenin import into nucleus (GO:0035414) | 4.01881141 |
| 69 | phospholipid efflux (GO:0033700) | 3.98777819 |
| 70 | regulation of cholesterol esterification (GO:0010872) | 3.91319736 |
| 71 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.90276416 |
| 72 | tyrosine metabolic process (GO:0006570) | 3.89848565 |
| 73 | fatty acid oxidation (GO:0019395) | 3.89435218 |
| 74 | fatty acid beta-oxidation (GO:0006635) | 3.89255206 |
| 75 | serine family amino acid metabolic process (GO:0009069) | 3.88862889 |
| 76 | fibrinolysis (GO:0042730) | 3.87975149 |
| 77 | aspartate family amino acid catabolic process (GO:0009068) | 3.85635225 |
| 78 | low-density lipoprotein particle remodeling (GO:0034374) | 3.84966573 |
| 79 | carnitine metabolic process (GO:0009437) | 3.84717682 |
| 80 | regulation of bile acid biosynthetic process (GO:0070857) | 3.83692316 |
| 81 | plasma lipoprotein particle assembly (GO:0034377) | 3.81886011 |
| 82 | glutathione derivative biosynthetic process (GO:1901687) | 3.81591946 |
| 83 | glutathione derivative metabolic process (GO:1901685) | 3.81591946 |
| 84 | lipid oxidation (GO:0034440) | 3.81163208 |
| 85 | benzene-containing compound metabolic process (GO:0042537) | 3.80838297 |
| 86 | tonic smooth muscle contraction (GO:0014820) | 3.80483541 |
| 87 | regulation of protein activation cascade (GO:2000257) | 3.78918797 |
| 88 | reverse cholesterol transport (GO:0043691) | 3.78600091 |
| 89 | aldehyde catabolic process (GO:0046185) | 3.76735683 |
| 90 | organic acid catabolic process (GO:0016054) | 3.76666171 |
| 91 | carboxylic acid catabolic process (GO:0046395) | 3.76666171 |
| 92 | coenzyme catabolic process (GO:0009109) | 3.74819177 |
| 93 | negative regulation of blood coagulation (GO:0030195) | 3.74214864 |
| 94 | negative regulation of hemostasis (GO:1900047) | 3.74214864 |
| 95 | negative regulation of coagulation (GO:0050819) | 3.71947704 |
| 96 | negative regulation of receptor-mediated endocytosis (GO:0048261) | 3.70935647 |
| 97 | regulation of cholesterol biosynthetic process (GO:0045540) | 3.70255059 |
| 98 | complement activation, alternative pathway (GO:0006957) | 3.69114203 |
| 99 | acetyl-CoA metabolic process (GO:0006084) | 3.68943197 |
| 100 | monocarboxylic acid catabolic process (GO:0072329) | 3.67749600 |
| 101 | plasma lipoprotein particle remodeling (GO:0034369) | 3.66494719 |
| 102 | protein-lipid complex remodeling (GO:0034368) | 3.66494719 |
| 103 | macromolecular complex remodeling (GO:0034367) | 3.66494719 |
| 104 | regulation of cholesterol homeostasis (GO:2000188) | 3.65813637 |
| 105 | valine metabolic process (GO:0006573) | 3.63057842 |
| 106 | glycine metabolic process (GO:0006544) | 3.62547703 |
| 107 | heme transport (GO:0015886) | 3.61784542 |
| 108 | lipopolysaccharide biosynthetic process (GO:0009103) | 3.60447343 |
| 109 | negative regulation of lipid transport (GO:0032369) | 3.59549048 |
| 110 | very long-chain fatty acid metabolic process (GO:0000038) | 3.58427326 |
| 111 | fatty acid catabolic process (GO:0009062) | 3.57187107 |
| 112 | exogenous drug catabolic process (GO:0042738) | 3.56603609 |
| 113 | imidazole-containing compound metabolic process (GO:0052803) | 3.56093392 |
| 114 | 2-oxoglutarate metabolic process (GO:0006103) | 3.54651586 |
| 115 | regulation of complement activation (GO:0030449) | 3.52333228 |
| 116 | branched-chain amino acid catabolic process (GO:0009083) | 3.50366655 |
| 117 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.49925798 |
| 118 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.48427526 |
| 119 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.48427526 |
| 120 | artery smooth muscle contraction (GO:0014824) | 3.47818300 |
| 121 | protein-lipid complex assembly (GO:0065005) | 3.44306840 |
| 122 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 3.43494811 |
| 123 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.42619269 |
| 124 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 3.41602765 |
| 125 | cholesterol homeostasis (GO:0042632) | 3.39880828 |
| 126 | positive regulation of cellular response to insulin stimulus (GO:1900078) | 3.39809629 |
| 127 | branched-chain amino acid metabolic process (GO:0009081) | 3.39205398 |
| 128 | phospholipid homeostasis (GO:0055091) | 3.38885802 |
| 129 | negative regulation of fatty acid transport (GO:2000192) | 3.38522866 |
| 130 | negative regulation of digestive system process (GO:0060457) | 3.38333661 |
| 131 | negative regulation of wound healing (GO:0061045) | 3.35135884 |
| 132 | regulation of cholesterol metabolic process (GO:0090181) | 3.33906116 |
| 133 | plasma lipoprotein particle organization (GO:0071827) | 3.30508934 |
| 134 | cholesterol efflux (GO:0033344) | 3.28957128 |
| 135 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800) | 3.28579581 |
| 136 | positive regulation of extracellular matrix organization (GO:1903055) | 3.28268522 |
| 137 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 3.20911290 |
| 138 | lipopolysaccharide metabolic process (GO:0008653) | 3.17945727 |
| 139 | regulation of low-density lipoprotein particle receptor biosynthetic process (GO:0045714) | 3.16622176 |
| 140 | positive regulation of insulin receptor signaling pathway (GO:0046628) | 3.16394997 |
| 141 | protein-lipid complex subunit organization (GO:0071825) | 3.13124967 |
| 142 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 3.10859211 |
| 143 | regulation of apoptotic cell clearance (GO:2000425) | 3.08124395 |
| 144 | positive regulation of smooth muscle cell migration (GO:0014911) | 3.03585437 |
| 145 | positive regulation of receptor biosynthetic process (GO:0010870) | 2.99928394 |
| 146 | hypotonic response (GO:0006971) | 2.98842636 |
| 147 | positive regulation of steroid biosynthetic process (GO:0010893) | 2.90553308 |
| 148 | positive regulation of hormone metabolic process (GO:0032352) | 2.86252991 |
| 149 | lipoprotein metabolic process (GO:0042157) | 2.85826460 |
| 150 | endodermal cell differentiation (GO:0035987) | 2.85675171 |
| 151 | regulation of Wnt signaling pathway, planar cell polarity pathway (GO:2000095) | 2.85430039 |
| 152 | gap junction assembly (GO:0016264) | 2.83863293 |
| 153 | exocrine pancreas development (GO:0031017) | 2.80752263 |
| 154 | positive regulation of hormone biosynthetic process (GO:0046886) | 2.79437669 |
| 155 | omega-hydroxylase P450 pathway (GO:0097267) | 2.79183520 |
| 156 | fatty acid homeostasis (GO:0055089) | 2.73219720 |
| 157 | glomerular basement membrane development (GO:0032836) | 2.73000815 |
| 158 | regulation of triglyceride metabolic process (GO:0090207) | 2.71727967 |
| 159 | axon regeneration (GO:0031103) | 2.71622054 |
| 160 | regulation of lipoprotein lipase activity (GO:0051004) | 2.71233990 |
| 161 | complement activation, classical pathway (GO:0006958) | 2.70988203 |
| 162 | basement membrane organization (GO:0071711) | 2.65137310 |
| 163 | positive regulation of blood coagulation (GO:0030194) | 2.64176155 |
| 164 | positive regulation of hemostasis (GO:1900048) | 2.64176155 |
| 165 | positive regulation of coagulation (GO:0050820) | 2.62330891 |
| 166 | respiratory tube development (GO:0030323) | 2.62267382 |
| 167 | positive regulation of wound healing (GO:0090303) | 2.59825153 |
| 168 | regulation of cholesterol transport (GO:0032374) | 2.58980347 |
| 169 | regulation of sterol transport (GO:0032371) | 2.58980347 |
| 170 | branch elongation of an epithelium (GO:0060602) | 2.56887060 |
| 171 | oxidative demethylation (GO:0070989) | 2.56631064 |
| 172 | peptide biosynthetic process (GO:0043043) | 2.56609448 |
| 173 | peptidyl-glutamic acid modification (GO:0018200) | 2.55930780 |
| 174 | protein activation cascade (GO:0072376) | 2.55644641 |
| 175 | vascular endothelial growth factor signaling pathway (GO:0038084) | 2.55331024 |
| 176 | regulation of metalloenzyme activity (GO:0048552) | 2.54167675 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 9.40744339 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 6.71287678 |
| 3 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 5.87596565 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.48019504 |
| 5 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 5.37220785 |
| 6 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.32114187 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.23588763 |
| 8 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.65593996 |
| 9 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.52685007 |
| 10 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.28922492 |
| 11 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.56597556 |
| 12 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.46843275 |
| 13 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 2.21007562 |
| 14 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 2.20543806 |
| 15 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.12203987 |
| 16 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.10299925 |
| 17 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.06576018 |
| 18 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 2.04771833 |
| 19 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.92979735 |
| 20 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.88144828 |
| 21 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.85753662 |
| 22 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.68419274 |
| 23 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.67405787 |
| 24 | CJUN_26792858_Chip-Seq_BT549_Human | 1.55718180 |
| 25 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.55294126 |
| 26 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.54998446 |
| 27 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.54933977 |
| 28 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.50910048 |
| 29 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.50525741 |
| 30 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.47820956 |
| 31 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.45791429 |
| 32 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.45218093 |
| 33 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.44990978 |
| 34 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.44657312 |
| 35 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.42653306 |
| 36 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.40279291 |
| 37 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.38074477 |
| 38 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.37076922 |
| 39 | VDR_22108803_ChIP-Seq_LS180_Human | 1.36902420 |
| 40 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.36524686 |
| 41 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.31678181 |
| 42 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.30543664 |
| 43 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.29907513 |
| 44 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.29417296 |
| 45 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.28950861 |
| 46 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.28173568 |
| 47 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 1.26733008 |
| 48 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.26014900 |
| 49 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.25932815 |
| 50 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.25784701 |
| 51 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.24712043 |
| 52 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.23153101 |
| 53 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.23056001 |
| 54 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.22062934 |
| 55 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.21662471 |
| 56 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.18666643 |
| 57 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.18472479 |
| 58 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 1.16031276 |
| 59 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.14261375 |
| 60 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.13385011 |
| 61 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.13283954 |
| 62 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.10838872 |
| 63 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.09922976 |
| 64 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.09683046 |
| 65 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.07872603 |
| 66 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.07227038 |
| 67 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.06236653 |
| 68 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.05985111 |
| 69 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.04141409 |
| 70 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.03348560 |
| 71 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.01376926 |
| 72 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 1.00349263 |
| 73 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.99217984 |
| 74 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.98318193 |
| 75 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.97615220 |
| 76 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.97511822 |
| 77 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.95475293 |
| 78 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.92919936 |
| 79 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.92233752 |
| 80 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.91839500 |
| 81 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 0.91248976 |
| 82 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.89869234 |
| 83 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.89422099 |
| 84 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 0.88834816 |
| 85 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.88296328 |
| 86 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.87319718 |
| 87 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.86588593 |
| 88 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.85682828 |
| 89 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.85577927 |
| 90 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.85398561 |
| 91 | GBX2_23144817_ChIP-Seq_PC3_Human | 0.84322391 |
| 92 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.83920032 |
| 93 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.83553158 |
| 94 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.83323048 |
| 95 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.82919895 |
| 96 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.82886479 |
| 97 | * STAT1_17558387_ChIP-Seq_HELA_Human | 0.82605477 |
| 98 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.82428496 |
| 99 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.82216043 |
| 100 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.82196014 |
| 101 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.82055864 |
| 102 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.81470014 |
| 103 | BRD4_25478319_ChIP-Seq_HGPS_Human | 0.81188376 |
| 104 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.81031538 |
| 105 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.80875192 |
| 106 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.79990324 |
| 107 | GATA1_19941826_ChIP-Seq_K562_Human | 0.78954212 |
| 108 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 0.78659916 |
| 109 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.78434286 |
| 110 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 0.78201949 |
| 111 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.78093703 |
| 112 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.76955356 |
| 113 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 0.76852830 |
| 114 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.76294184 |
| 115 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.75376652 |
| 116 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.74364400 |
| 117 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.73867582 |
| 118 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.73829801 |
| 119 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.72516528 |
| 120 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.72386203 |
| 121 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.71948377 |
| 122 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.70917889 |
| 123 | RXR_22108803_ChIP-Seq_LS180_Human | 0.69562613 |
| 124 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.69152732 |
| 125 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.68833654 |
| 126 | CBP_21632823_ChIP-Seq_H3396_Human | 0.68208718 |
| 127 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.68104214 |
| 128 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.66668926 |
| 129 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.66463531 |
| 130 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.66303510 |
| 131 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.64738232 |
| 132 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.64281535 |
| 133 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.64281535 |
| 134 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.64246341 |
| 135 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.64001400 |
| 136 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.63962024 |
| 137 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.63587261 |
| 138 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.62527884 |
| 139 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.62366652 |
| 140 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.62099781 |
| 141 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.61951435 |
| 142 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.61122927 |
| 143 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.60845339 |
| 144 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.60256211 |
| 145 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.59714768 |
| 146 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.59144870 |
| 147 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.58964803 |
| 148 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.57816110 |
| 149 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.57748397 |
| 150 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.57447821 |
| 151 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.57115010 |
| 152 | KDM2B_26808549_Chip-Seq_REH_Human | 0.56024680 |
| 153 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.55848462 |
| 154 | * P63_20808887_ChIP-Seq_KERATINOCYTES_Human | 0.55048172 |
| 155 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.54818918 |
| 156 | AR_20517297_ChIP-Seq_VCAP_Human | 0.53715815 |
| 157 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.53330323 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 7.29459691 |
| 2 | MP0002139_abnormal_hepatobiliary_system | 7.13485999 |
| 3 | MP0008004_abnormal_stomach_pH | 6.11799474 |
| 4 | MP0005085_abnormal_gallbladder_physiolo | 5.68014704 |
| 5 | MP0005365_abnormal_bile_salt | 5.12790961 |
| 6 | MP0008875_abnormal_xenobiotic_pharmacok | 4.39834921 |
| 7 | MP0003806_abnormal_nucleotide_metabolis | 4.38210074 |
| 8 | MP0008438_abnormal_cutaneous_collagen | 3.81295440 |
| 9 | MP0009840_abnormal_foam_cell | 3.53707870 |
| 10 | MP0001958_emphysema | 3.35882438 |
| 11 | MP0000566_synostosis | 3.31993841 |
| 12 | MP0010386_abnormal_urinary_bladder | 3.31494032 |
| 13 | MP0003252_abnormal_bile_duct | 3.25238044 |
| 14 | MP0003279_aneurysm | 3.15597675 |
| 15 | MP0001666_abnormal_nutrient_absorption | 2.99666947 |
| 16 | MP0010329_abnormal_lipoprotein_level | 2.93543795 |
| 17 | MP0005083_abnormal_biliary_tract | 2.84874520 |
| 18 | MP0001984_abnormal_olfaction | 2.76117371 |
| 19 | MP0004272_abnormal_basement_membrane | 2.74807580 |
| 20 | MP0005503_abnormal_tendon_morphology | 2.71717177 |
| 21 | MP0005332_abnormal_amino_acid | 2.69562540 |
| 22 | MP0004019_abnormal_vitamin_homeostasis | 2.68449016 |
| 23 | MP0003195_calcinosis | 2.64071740 |
| 24 | MP0000751_myopathy | 2.57077684 |
| 25 | MP0004883_abnormal_blood_vessel | 2.25088466 |
| 26 | MP0005275_abnormal_skin_tensile | 2.13131206 |
| 27 | MP0001664_abnormal_digestion | 2.07523038 |
| 28 | MP0005451_abnormal_body_composition | 2.00552878 |
| 29 | MP0005164_abnormal_response_to | 1.94345939 |
| 30 | MP0003191_abnormal_cellular_cholesterol | 1.93663251 |
| 31 | MP0003868_abnormal_feces_composition | 1.90801485 |
| 32 | MP0002138_abnormal_hepatobiliary_system | 1.87769483 |
| 33 | MP0000003_abnormal_adipose_tissue | 1.87553051 |
| 34 | MP0001873_stomach_inflammation | 1.78332710 |
| 35 | MP0002118_abnormal_lipid_homeostasis | 1.76250939 |
| 36 | MP0000609_abnormal_liver_physiology | 1.63410743 |
| 37 | MP0009643_abnormal_urine_homeostasis | 1.62596405 |
| 38 | MP0002736_abnormal_nociception_after | 1.60706228 |
| 39 | MP0006054_spinal_hemorrhage | 1.47688990 |
| 40 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.46766706 |
| 41 | MP0010234_abnormal_vibrissa_follicle | 1.45595469 |
| 42 | MP0004043_abnormal_pH_regulation | 1.43276918 |
| 43 | MP0005595_abnormal_vascular_smooth | 1.41111893 |
| 44 | MP0003705_abnormal_hypodermis_morpholog | 1.40676628 |
| 45 | MP0005319_abnormal_enzyme/_coenzyme | 1.39400053 |
| 46 | MP0000013_abnormal_adipose_tissue | 1.37759456 |
| 47 | MP0005058_abnormal_lysosome_morphology | 1.35142468 |
| 48 | MP0000470_abnormal_stomach_morphology | 1.33374111 |
| 49 | MP0005636_abnormal_mineral_homeostasis | 1.30770408 |
| 50 | MP0003566_abnormal_cell_adhesion | 1.27978303 |
| 51 | MP0003011_delayed_dark_adaptation | 1.27498306 |
| 52 | MP0000767_abnormal_smooth_muscle | 1.25036219 |
| 53 | MP0002102_abnormal_ear_morphology | 1.20842354 |
| 54 | MP0002295_abnormal_pulmonary_circulatio | 1.19849812 |
| 55 | MP0002876_abnormal_thyroid_physiology | 1.17745781 |
| 56 | MP0003186_abnormal_redox_activity | 1.15912391 |
| 57 | MP0005375_adipose_tissue_phenotype | 1.14205331 |
| 58 | MP0002735_abnormal_chemical_nociception | 1.09801482 |
| 59 | MP0005023_abnormal_wound_healing | 1.09740216 |
| 60 | MP0009053_abnormal_anal_canal | 1.08960552 |
| 61 | MP0005508_abnormal_skeleton_morphology | 1.07637248 |
| 62 | MP0001663_abnormal_digestive_system | 1.07493101 |
| 63 | MP0005381_digestive/alimentary_phenotyp | 1.03265489 |
| 64 | MP0003115_abnormal_respiratory_system | 1.01870841 |
| 65 | MP0001764_abnormal_homeostasis | 1.01076532 |
| 66 | MP0000249_abnormal_blood_vessel | 1.00774552 |
| 67 | MP0003879_abnormal_hair_cell | 0.99454730 |
| 68 | MP0009780_abnormal_chondrocyte_physiolo | 0.98545034 |
| 69 | MP0000462_abnormal_digestive_system | 0.95975600 |
| 70 | MP0001756_abnormal_urination | 0.92198746 |
| 71 | MP0003656_abnormal_erythrocyte_physiolo | 0.91218764 |
| 72 | MP0002254_reproductive_system_inflammat | 0.88235807 |
| 73 | MP0002060_abnormal_skin_morphology | 0.87966289 |
| 74 | MP0002998_abnormal_bone_remodeling | 0.84068418 |
| 75 | MP0004381_abnormal_hair_follicle | 0.83719550 |
| 76 | MP0009764_decreased_sensitivity_to | 0.83677366 |
| 77 | MP0002136_abnormal_kidney_physiology | 0.83514857 |
| 78 | MP0000343_altered_response_to | 0.81714434 |
| 79 | MP0009642_abnormal_blood_homeostasis | 0.80165287 |
| 80 | MP0000920_abnormal_myelination | 0.78944604 |
| 81 | MP0002108_abnormal_muscle_morphology | 0.77723409 |
| 82 | MP0006082_CNS_inflammation | 0.77004423 |
| 83 | MP0001765_abnormal_ion_homeostasis | 0.76801947 |
| 84 | MP0004264_abnormal_extraembryonic_tissu | 0.76694168 |
| 85 | MP0000639_abnormal_adrenal_gland | 0.75426204 |
| 86 | MP0000598_abnormal_liver_morphology | 0.74802373 |
| 87 | MP0005165_increased_susceptibility_to | 0.74259870 |
| 88 | MP0003122_maternal_imprinting | 0.73242877 |
| 89 | MP0006036_abnormal_mitochondrial_physio | 0.72433695 |
| 90 | MP0003385_abnormal_body_wall | 0.72215029 |
| 91 | MP0005647_abnormal_sex_gland | 0.71635381 |
| 92 | MP0001533_abnormal_skeleton_physiology | 0.71298618 |
| 93 | MP0002909_abnormal_adrenal_gland | 0.69954422 |
| 94 | MP0002078_abnormal_glucose_homeostasis | 0.68916623 |
| 95 | MP0000477_abnormal_intestine_morphology | 0.68652989 |
| 96 | MP0001542_abnormal_bone_strength | 0.66982264 |
| 97 | MP0000604_amyloidosis | 0.66470801 |
| 98 | MP0001486_abnormal_startle_reflex | 0.65706831 |
| 99 | MP0009115_abnormal_fat_cell | 0.65161126 |
| 100 | MP0005084_abnormal_gallbladder_morpholo | 0.64344839 |
| 101 | MP0003634_abnormal_glial_cell | 0.63411626 |
| 102 | MP0003724_increased_susceptibility_to | 0.62896057 |
| 103 | MP0005334_abnormal_fat_pad | 0.62317888 |
| 104 | MP0009278_abnormal_bone_marrow | 0.61833594 |
| 105 | MP0009763_increased_sensitivity_to | 0.61830340 |
| 106 | MP0001348_abnormal_lacrimal_gland | 0.61005470 |
| 107 | MP0000538_abnormal_urinary_bladder | 0.60875196 |
| 108 | MP0005390_skeleton_phenotype | 0.60834920 |
| 109 | MP0009697_abnormal_copulation | 0.59804801 |
| 110 | MP0008469_abnormal_protein_level | 0.59784046 |
| 111 | MP0002796_impaired_skin_barrier | 0.59606302 |
| 112 | MP0000579_abnormal_nail_morphology | 0.58536474 |
| 113 | MP0001879_abnormal_lymphatic_vessel | 0.58437587 |
| 114 | MP0003943_abnormal_hepatobiliary_system | 0.57637339 |
| 115 | MP0002168_other_aberrant_phenotype | 0.57335300 |
| 116 | MP0005535_abnormal_body_temperature | 0.57256175 |
| 117 | MP0004233_abnormal_muscle_weight | 0.57034496 |
| 118 | MP0001661_extended_life_span | 0.56716906 |
| 119 | MP0005266_abnormal_metabolism | 0.56163828 |
| 120 | MP0004185_abnormal_adipocyte_glucose | 0.55920356 |
| 121 | MP0005646_abnormal_pituitary_gland | 0.55830493 |
| 122 | MP0008775_abnormal_heart_ventricle | 0.55236185 |
| 123 | MP0002128_abnormal_blood_circulation | 0.54928605 |
| 124 | MP0010368_abnormal_lymphatic_system | 0.54296755 |
| 125 | MP0003953_abnormal_hormone_level | 0.54128393 |
| 126 | MP0004130_abnormal_muscle_cell | 0.52830548 |
| 127 | MP0009765_abnormal_xenobiotic_induced | 0.52777302 |
| 128 | MP0005220_abnormal_exocrine_pancreas | 0.52478918 |
| 129 | MP0003300_gastrointestinal_ulcer | 0.52244000 |
| 130 | MP0005408_hypopigmentation | 0.51277580 |
| 131 | MP0005376_homeostasis/metabolism_phenot | 0.50569131 |
| 132 | MP0003638_abnormal_response/metabolism_ | 0.50146008 |
| 133 | MP0010155_abnormal_intestine_physiology | 0.47345519 |
| 134 | MP0003718_maternal_effect | 0.46064011 |
| 135 | MP0003329_amyloid_beta_deposits | 0.44523763 |
| 136 | MP0002971_abnormal_brown_adipose | 0.43324909 |
| 137 | MP0000230_abnormal_systemic_arterial | 0.42098362 |
| 138 | MP0005166_decreased_susceptibility_to | 0.41647254 |
| 139 | MP0000647_abnormal_sebaceous_gland | 0.41395300 |
| 140 | MP0004782_abnormal_surfactant_physiolog | 0.40917297 |
| 141 | MP0005395_other_phenotype | 0.40408251 |
| 142 | MP0002837_dystrophic_cardiac_calcinosis | 0.39406236 |
| 143 | MP0005167_abnormal_blood-brain_barrier | 0.38899889 |
| 144 | MP0003075_altered_response_to | 0.38350284 |
| 145 | MP0002822_catalepsy | 0.36908309 |
| 146 | MP0000467_abnormal_esophagus_morphology | 0.36550702 |
| 147 | MP0005448_abnormal_energy_balance | 0.35627828 |
| 148 | MP0002928_abnormal_bile_duct | 0.34842833 |
| 149 | MP0009384_cardiac_valve_regurgitation | 0.33802470 |
| 150 | MP0008874_decreased_physiological_sensi | 0.33206396 |
| 151 | MP0003690_abnormal_glial_cell | 0.33202145 |
| 152 | MP0001243_abnormal_dermal_layer | 0.33051314 |
| 153 | MP0002970_abnormal_white_adipose | 0.32948854 |
| 154 | MP0004147_increased_porphyrin_level | 0.32760532 |
| 155 | MP0005666_abnormal_adipose_tissue | 0.32233247 |
| 156 | MP0008873_increased_physiological_sensi | 0.31234685 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Intrahepatic cholestasis (HP:0001406) | 6.16643312 |
| 2 | Deep venous thrombosis (HP:0002625) | 5.95455331 |
| 3 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 5.82137282 |
| 4 | Menstrual irregularities (HP:0000858) | 5.53834505 |
| 5 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 5.36694162 |
| 6 | Hyperglycinuria (HP:0003108) | 5.30518748 |
| 7 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 5.20767015 |
| 8 | Xanthomatosis (HP:0000991) | 4.78521782 |
| 9 | Prolonged partial thromboplastin time (HP:0003645) | 4.72866932 |
| 10 | Abnormality of glycine metabolism (HP:0010895) | 4.71939966 |
| 11 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.71939966 |
| 12 | Abnormality of pyrimidine metabolism (HP:0004353) | 4.69952083 |
| 13 | Hypobetalipoproteinemia (HP:0003563) | 4.67309097 |
| 14 | Growth hormone excess (HP:0000845) | 4.63724258 |
| 15 | Premature rupture of membranes (HP:0001788) | 4.51121399 |
| 16 | Ketosis (HP:0001946) | 4.26594674 |
| 17 | Hyperglycinemia (HP:0002154) | 4.24516568 |
| 18 | Bilateral sensorineural hearing impairment (HP:0008619) | 4.19875207 |
| 19 | Abnormality of nucleobase metabolism (HP:0010932) | 4.15134391 |
| 20 | Hyperammonemia (HP:0001987) | 4.04491821 |
| 21 | Gout (HP:0001997) | 4.01047206 |
| 22 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.98977347 |
| 23 | Abnormal glucose tolerance (HP:0001952) | 3.94486509 |
| 24 | Ketoacidosis (HP:0001993) | 3.89668355 |
| 25 | Abnormality of purine metabolism (HP:0004352) | 3.87725544 |
| 26 | Joint hemorrhage (HP:0005261) | 3.86129978 |
| 27 | Hyperlipoproteinemia (HP:0010980) | 3.82257562 |
| 28 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.79783707 |
| 29 | Systemic lupus erythematosus (HP:0002725) | 3.76714100 |
| 30 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.74333650 |
| 31 | Glucose intolerance (HP:0000833) | 3.67354861 |
| 32 | Delayed CNS myelination (HP:0002188) | 3.63128492 |
| 33 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.61698692 |
| 34 | Mitral stenosis (HP:0001718) | 3.61165794 |
| 35 | Distal lower limb muscle weakness (HP:0009053) | 3.60767725 |
| 36 | Complement deficiency (HP:0004431) | 3.57326421 |
| 37 | Fat malabsorption (HP:0002630) | 3.57240196 |
| 38 | Conjugated hyperbilirubinemia (HP:0002908) | 3.57054100 |
| 39 | Broad metatarsal (HP:0001783) | 3.55411052 |
| 40 | Hypolipoproteinemia (HP:0010981) | 3.52968307 |
| 41 | Protrusio acetabuli (HP:0003179) | 3.51629838 |
| 42 | Abnormality of proline metabolism (HP:0010907) | 3.51600183 |
| 43 | Hydroxyprolinuria (HP:0003080) | 3.51600183 |
| 44 | Stridor (HP:0010307) | 3.39883523 |
| 45 | Muscle fiber splitting (HP:0003555) | 3.37880322 |
| 46 | Asymmetry of the thorax (HP:0001555) | 3.36660194 |
| 47 | Hypoglycemic coma (HP:0001325) | 3.33847041 |
| 48 | Malnutrition (HP:0004395) | 3.29370381 |
| 49 | Hyperuricemia (HP:0002149) | 3.26056993 |
| 50 | Increased purine levels (HP:0004368) | 3.26056993 |
| 51 | Carpal bone hypoplasia (HP:0001498) | 3.22372667 |
| 52 | Diaphragmatic weakness (HP:0009113) | 3.18728171 |
| 53 | Vascular calcification (HP:0004934) | 3.15150001 |
| 54 | Abnormality of the distal phalanges of the toes (HP:0010182) | 3.15087890 |
| 55 | Hypoalphalipoproteinemia (HP:0003233) | 3.13785885 |
| 56 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.12310582 |
| 57 | Abnormality of serum amino acid levels (HP:0003112) | 3.10236839 |
| 58 | Metabolic acidosis (HP:0001942) | 3.10127356 |
| 59 | Upper limb amyotrophy (HP:0009129) | 3.06752022 |
| 60 | Distal upper limb amyotrophy (HP:0007149) | 3.06752022 |
| 61 | Epidermoid cyst (HP:0200040) | 3.01370117 |
| 62 | Hand muscle atrophy (HP:0009130) | 3.00258654 |
| 63 | Abnormality of the middle phalanges of the toes (HP:0010183) | 2.97105180 |
| 64 | Aortic dissection (HP:0002647) | 2.92245022 |
| 65 | Dicarboxylic aciduria (HP:0003215) | 2.86405284 |
| 66 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.86405284 |
| 67 | Proximal tubulopathy (HP:0000114) | 2.84544947 |
| 68 | Cardiovascular calcification (HP:0011915) | 2.83266112 |
| 69 | Hepatocellular carcinoma (HP:0001402) | 2.82908003 |
| 70 | Late onset (HP:0003584) | 2.80668834 |
| 71 | Hyperbilirubinemia (HP:0002904) | 2.80458701 |
| 72 | Abnormality of methionine metabolism (HP:0010901) | 2.79138657 |
| 73 | Aortic aneurysm (HP:0004942) | 2.78181045 |
| 74 | Abnormality of the common coagulation pathway (HP:0010990) | 2.75343020 |
| 75 | Abnormality of the intrinsic pathway (HP:0010989) | 2.74672766 |
| 76 | Spinal muscular atrophy (HP:0007269) | 2.72760577 |
| 77 | Lethargy (HP:0001254) | 2.68380788 |
| 78 | Aplasia of the musculature (HP:0100854) | 2.64881066 |
| 79 | Limb-girdle muscle atrophy (HP:0003797) | 2.64875539 |
| 80 | Abnormality of vitamin metabolism (HP:0100508) | 2.63502117 |
| 81 | Neonatal short-limb short stature (HP:0008921) | 2.61335905 |
| 82 | Nonimmune hydrops fetalis (HP:0001790) | 2.59957457 |
| 83 | Vacuolated lymphocytes (HP:0001922) | 2.59751567 |
| 84 | Thin bony cortex (HP:0002753) | 2.57448592 |
| 85 | Alkalosis (HP:0001948) | 2.57223059 |
| 86 | Spastic diplegia (HP:0001264) | 2.57080965 |
| 87 | Steatorrhea (HP:0002570) | 2.54063681 |
| 88 | Abnormality of complement system (HP:0005339) | 2.51777567 |
| 89 | Mesangial abnormality (HP:0001966) | 2.50928582 |
| 90 | Facial shape deformation (HP:0011334) | 2.50573168 |
| 91 | Potter facies (HP:0002009) | 2.50573168 |
| 92 | Neurofibrillary tangles (HP:0002185) | 2.47293438 |
| 93 | Increased variability in muscle fiber diameter (HP:0003557) | 2.45013548 |
| 94 | Glomerulonephritis (HP:0000099) | 2.44526305 |
| 95 | Hypoglycemic seizures (HP:0002173) | 2.43675041 |
| 96 | Spinal cord compression (HP:0002176) | 2.43034642 |
| 97 | Aplasia/Hypoplasia involving the musculature (HP:0001460) | 2.34676371 |
| 98 | Renal cortical cysts (HP:0000803) | 2.33610491 |
| 99 | Aortic valve stenosis (HP:0001650) | 2.33132599 |
| 100 | Generalized aminoaciduria (HP:0002909) | 2.31217867 |
| 101 | Hypercholesterolemia (HP:0003124) | 2.30592857 |
| 102 | Impaired pain sensation (HP:0007328) | 2.30589189 |
| 103 | Abnormality of pain sensation (HP:0010832) | 2.30589189 |
| 104 | Pancreatitis (HP:0001733) | 2.26935809 |
| 105 | Sensorimotor neuropathy (HP:0007141) | 2.26536327 |
| 106 | Abnormality of glycolipid metabolism (HP:0010969) | 2.26340378 |
| 107 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.26340378 |
| 108 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.26340378 |
| 109 | Enlarged kidneys (HP:0000105) | 2.26051527 |
| 110 | Rickets (HP:0002748) | 2.25677458 |
| 111 | Vertebral compression fractures (HP:0002953) | 2.25671984 |
| 112 | Oligomenorrhea (HP:0000876) | 2.24359835 |
| 113 | Abnormality of carpal bone ossification (HP:0006257) | 2.22431905 |
| 114 | Vascular tortuosity (HP:0004948) | 2.21759828 |
| 115 | Hyperactive renin-angiotensin system (HP:0000841) | 2.20657180 |
| 116 | Duplicated collecting system (HP:0000081) | 2.20131745 |
| 117 | Abnormality of urine glucose concentration (HP:0011016) | 2.20118758 |
| 118 | Glycosuria (HP:0003076) | 2.20118758 |
| 119 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.19665180 |
| 120 | Abnormality of chloride homeostasis (HP:0011422) | 2.19606252 |
| 121 | Pulmonary artery stenosis (HP:0004415) | 2.18170566 |
| 122 | Metabolic alkalosis (HP:0200114) | 2.16686336 |
| 123 | Peritonitis (HP:0002586) | 2.16134902 |
| 124 | Ileus (HP:0002595) | 2.16134514 |
| 125 | Reticulocytopenia (HP:0001896) | 2.15579244 |
| 126 | Vomiting (HP:0002013) | 2.14632089 |
| 127 | Obstructive sleep apnea (HP:0002870) | 2.13890768 |
| 128 | Torticollis (HP:0000473) | 2.12157478 |
| 129 | Right ventricular cardiomyopathy (HP:0011663) | 2.11944422 |
| 130 | Esophageal varix (HP:0002040) | 2.11691915 |
| 131 | Shallow orbits (HP:0000586) | 2.11681722 |
| 132 | Hypokalemic alkalosis (HP:0001949) | 2.11210477 |
| 133 | Sleep apnea (HP:0010535) | 2.10894834 |
| 134 | Polycythemia (HP:0001901) | 2.10590168 |
| 135 | Megaloblastic anemia (HP:0001889) | 2.09918592 |
| 136 | Abnormality of alanine metabolism (HP:0010916) | 2.09389689 |
| 137 | Hyperalaninemia (HP:0003348) | 2.09389689 |
| 138 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.09389689 |
| 139 | Hemorrhage of the eye (HP:0011885) | 2.09059672 |
| 140 | Menorrhagia (HP:0000132) | 2.08433687 |
| 141 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 2.08102444 |
| 142 | Round ear (HP:0100830) | 2.08039883 |
| 143 | Abnormality of vitamin B metabolism (HP:0004340) | 2.06644209 |
| 144 | Cerebral edema (HP:0002181) | 2.05836594 |
| 145 | Aortic regurgitation (HP:0001659) | 2.04105678 |
| 146 | Amyloidosis (HP:0011034) | 2.02861223 |
| 147 | Brushfield spots (HP:0001088) | 2.02272853 |
| 148 | Abnormality of dentin (HP:0010299) | 2.01871000 |
| 149 | Neonatal onset (HP:0003623) | 1.98633548 |
| 150 | J-shaped sella turcica (HP:0002680) | 1.98123523 |
| 151 | Hypophosphatemic rickets (HP:0004912) | 1.96895853 |
| 152 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.96656821 |
| 153 | Wrist flexion contracture (HP:0001239) | 1.96588222 |
| 154 | Myocardial infarction (HP:0001658) | 1.96279511 |
| 155 | Flat acetabular roof (HP:0003180) | 1.95659125 |
| 156 | Abnormal gallbladder physiology (HP:0012438) | 1.95045725 |
| 157 | Cholecystitis (HP:0001082) | 1.95045725 |
| 158 | Arterial tortuosity (HP:0005116) | 1.95032906 |
| 159 | Status epilepticus (HP:0002133) | 1.94983442 |
| 160 | Hyperventilation (HP:0002883) | 1.94554481 |
| 161 | Limited hip movement (HP:0008800) | 1.93155697 |
| 162 | Aplasia/Hypoplasia involving the carpal bones (HP:0006502) | 1.92693825 |
| 163 | Abnormal ossification of hand bones (HP:0005921) | 1.92107736 |
| 164 | Nephrolithiasis (HP:0000787) | 1.91646625 |
| 165 | Irritability (HP:0000737) | 1.90191304 |
| 166 | Purpura (HP:0000979) | 1.89228439 |
| 167 | Gowers sign (HP:0003391) | 1.88695151 |
| 168 | Abnormality of the calf musculature (HP:0001430) | 1.88564057 |
| 169 | Natal tooth (HP:0000695) | 1.87810391 |
| 170 | Symptomatic seizures (HP:0011145) | 1.86511427 |
| 171 | Coxa vara (HP:0002812) | 1.85658848 |
| 172 | Joint stiffness (HP:0001387) | 1.82831140 |
| 173 | Acanthocytosis (HP:0001927) | 1.82523196 |
| 174 | Cervical subluxation (HP:0003308) | 1.82146973 |
| 175 | Soft skin (HP:0000977) | 1.80921858 |
| 176 | Left ventricular hypertrophy (HP:0001712) | 1.80809976 |
| 177 | Biconcave vertebral bodies (HP:0004586) | 1.80524684 |
| 178 | Knee flexion contracture (HP:0006380) | 1.78484145 |
| 179 | Bladder diverticulum (HP:0000015) | 1.78287349 |
| 180 | Rough bone trabeculation (HP:0100670) | 1.76003925 |
| 181 | Tubulointerstitial fibrosis (HP:0005576) | 1.75862208 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ERBB4 | 5.16210715 |
| 2 | BCKDK | 4.67476623 |
| 3 | TAOK3 | 3.93349032 |
| 4 | WNK4 | 3.54461573 |
| 5 | MST1R | 3.46978679 |
| 6 | WNK3 | 3.41516377 |
| 7 | EIF2AK1 | 3.16412149 |
| 8 | LATS1 | 2.77414116 |
| 9 | FGFR4 | 2.75162765 |
| 10 | PIK3CG | 2.55436529 |
| 11 | PDK4 | 2.48813730 |
| 12 | PDK3 | 2.48813730 |
| 13 | CCNB1 | 2.35809352 |
| 14 | MAP3K12 | 2.34412994 |
| 15 | OXSR1 | 2.34299029 |
| 16 | SIK1 | 2.25653499 |
| 17 | MAP3K9 | 2.22862588 |
| 18 | TESK1 | 2.21722394 |
| 19 | FRK | 2.20568895 |
| 20 | LMTK2 | 1.96359764 |
| 21 | LIMK1 | 1.95483468 |
| 22 | ERN1 | 1.91089946 |
| 23 | STK39 | 1.87390714 |
| 24 | KIT | 1.87355252 |
| 25 | INSRR | 1.83922749 |
| 26 | DDR2 | 1.74972176 |
| 27 | NUAK1 | 1.74308086 |
| 28 | NEK9 | 1.71060914 |
| 29 | TTN | 1.70579082 |
| 30 | PDK2 | 1.51877914 |
| 31 | MAP3K13 | 1.51183631 |
| 32 | MAP2K6 | 1.47529893 |
| 33 | TNK2 | 1.41944628 |
| 34 | RIPK1 | 1.40396099 |
| 35 | PTK2B | 1.35517490 |
| 36 | EPHB2 | 1.31990896 |
| 37 | NTRK1 | 1.31270596 |
| 38 | PDGFRB | 1.28451872 |
| 39 | PKN2 | 1.27461269 |
| 40 | MET | 1.20353300 |
| 41 | BLK | 1.19463055 |
| 42 | PTK6 | 1.13500572 |
| 43 | MST4 | 1.10132795 |
| 44 | PRKCG | 1.07542611 |
| 45 | EPHA4 | 1.06135352 |
| 46 | KSR2 | 1.06117722 |
| 47 | EPHA2 | 1.04437951 |
| 48 | SRPK1 | 1.00077915 |
| 49 | MAP2K4 | 1.00012625 |
| 50 | MAPK13 | 0.99311913 |
| 51 | TYK2 | 0.98145161 |
| 52 | PDPK1 | 0.95824396 |
| 53 | CDK12 | 0.95416038 |
| 54 | PAK2 | 0.91948778 |
| 55 | TLK1 | 0.88584780 |
| 56 | PRKAA2 | 0.88305982 |
| 57 | CAMK2B | 0.87724478 |
| 58 | STK16 | 0.86559445 |
| 59 | PDK1 | 0.85936254 |
| 60 | GRK1 | 0.84546282 |
| 61 | MAPK7 | 0.79987799 |
| 62 | CDC42BPA | 0.79338102 |
| 63 | STK38 | 0.77127641 |
| 64 | ERBB2 | 0.76938383 |
| 65 | FLT3 | 0.76142694 |
| 66 | ADRBK1 | 0.75150589 |
| 67 | ZAP70 | 0.74413169 |
| 68 | MARK1 | 0.72352712 |
| 69 | ERBB3 | 0.71097107 |
| 70 | PRKG2 | 0.69485484 |
| 71 | PAK4 | 0.68932453 |
| 72 | CSF1R | 0.68491316 |
| 73 | MAP3K6 | 0.67756009 |
| 74 | DYRK1A | 0.67243394 |
| 75 | TRIB3 | 0.66450211 |
| 76 | KSR1 | 0.64701393 |
| 77 | MAP2K1 | 0.64474745 |
| 78 | PRPF4B | 0.64375264 |
| 79 | GRK6 | 0.63277842 |
| 80 | ABL2 | 0.62935984 |
| 81 | MAP3K7 | 0.62483112 |
| 82 | TESK2 | 0.62474790 |
| 83 | SRC | 0.61687502 |
| 84 | MAPK11 | 0.60674742 |
| 85 | PRKAA1 | 0.59744366 |
| 86 | PRKACB | 0.59030263 |
| 87 | WNK1 | 0.58880150 |
| 88 | MYLK | 0.57662974 |
| 89 | MAPKAPK3 | 0.56256671 |
| 90 | EPHB1 | 0.55367859 |
| 91 | INSR | 0.55057799 |
| 92 | DAPK2 | 0.54318521 |
| 93 | MUSK | 0.54061055 |
| 94 | DAPK3 | 0.53022988 |
| 95 | MAP3K14 | 0.52631102 |
| 96 | JAK1 | 0.52143733 |
| 97 | TEC | 0.50887111 |
| 98 | MAP3K11 | 0.50656936 |
| 99 | CDK6 | 0.50205536 |
| 100 | PIM2 | 0.49836609 |
| 101 | JAK2 | 0.49768970 |
| 102 | PRKACA | 0.49349401 |
| 103 | RPS6KA2 | 0.49342055 |
| 104 | CSNK1D | 0.48366737 |
| 105 | MAP2K2 | 0.47593693 |
| 106 | CDK4 | 0.46865893 |
| 107 | PTK2 | 0.46621482 |
| 108 | CDK8 | 0.44569986 |
| 109 | TRPM7 | 0.43717169 |
| 110 | JAK3 | 0.43485903 |
| 111 | MAP3K3 | 0.42819166 |
| 112 | CDK9 | 0.42754483 |
| 113 | IGF1R | 0.41122817 |
| 114 | PRKCZ | 0.40679372 |
| 115 | CAMK2A | 0.40562295 |
| 116 | MAP3K2 | 0.40559248 |
| 117 | PRKD2 | 0.39388326 |
| 118 | GRK7 | 0.39051776 |
| 119 | MAP3K1 | 0.38348971 |
| 120 | GSK3A | 0.37840602 |
| 121 | MAP3K10 | 0.37767132 |
| 122 | FYN | 0.37246298 |
| 123 | PRKCE | 0.36609045 |
| 124 | MAP2K3 | 0.35487996 |
| 125 | MAP4K1 | 0.35092498 |
| 126 | PRKCQ | 0.34984947 |
| 127 | PRKACG | 0.34450336 |
| 128 | TIE1 | 0.33722503 |
| 129 | PAK3 | 0.33719372 |
| 130 | MOS | 0.33179423 |
| 131 | EPHA3 | 0.32539779 |
| 132 | TGFBR2 | 0.32392726 |
| 133 | FER | 0.31965454 |
| 134 | ARAF | 0.31843307 |
| 135 | BMX | 0.31613178 |
| 136 | MAPK4 | 0.29438114 |
| 137 | SGK1 | 0.28433724 |
| 138 | KDR | 0.27465513 |
| 139 | MAPK12 | 0.27381135 |
| 140 | LRRK2 | 0.27357865 |
| 141 | SGK494 | 0.26756635 |
| 142 | SGK223 | 0.26756635 |
| 143 | CSK | 0.26011997 |
| 144 | STK10 | 0.25875071 |
| 145 | EIF2AK2 | 0.25075265 |
| 146 | FGFR2 | 0.24515437 |
| 147 | CAMK2G | 0.21078988 |
| 148 | ROCK1 | 0.20533081 |
| 149 | PDGFRA | 0.17700997 |
| 150 | PRKCA | 0.17236192 |
| 151 | PRKCI | 0.16764295 |
| 152 | STK38L | 0.15581547 |
| 153 | PIK3CA | 0.14610417 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.66663913 |
| 2 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.47992713 |
| 3 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.76184644 |
| 4 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.75765235 |
| 5 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.67581235 |
| 6 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.65604111 |
| 7 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.60109991 |
| 8 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.58162623 |
| 9 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.56909942 |
| 10 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.45935709 |
| 11 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.45755570 |
| 12 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.42721315 |
| 13 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.41460847 |
| 14 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 2.35854965 |
| 15 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.23344431 |
| 16 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.21860938 |
| 17 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.19232523 |
| 18 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.10759455 |
| 19 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 2.08968754 |
| 20 | Peroxisome_Homo sapiens_hsa04146 | 2.07611979 |
| 21 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 2.07084135 |
| 22 | Histidine metabolism_Homo sapiens_hsa00340 | 2.06246800 |
| 23 | Retinol metabolism_Homo sapiens_hsa00830 | 1.88398911 |
| 24 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.87390131 |
| 25 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.86925519 |
| 26 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.85672314 |
| 27 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.75304674 |
| 28 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.72708792 |
| 29 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.72353177 |
| 30 | Bile secretion_Homo sapiens_hsa04976 | 1.71578340 |
| 31 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.62705838 |
| 32 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.61265788 |
| 33 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.61127834 |
| 34 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.58071655 |
| 35 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.48877690 |
| 36 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.47866905 |
| 37 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.43605106 |
| 38 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.42393341 |
| 39 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.40271892 |
| 40 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.31455018 |
| 41 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.28360566 |
| 42 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.26321909 |
| 43 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.25899012 |
| 44 | Lysosome_Homo sapiens_hsa04142 | 1.25373762 |
| 45 | Pertussis_Homo sapiens_hsa05133 | 1.23964789 |
| 46 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.23907113 |
| 47 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.21845366 |
| 48 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.21569718 |
| 49 | ABC transporters_Homo sapiens_hsa02010 | 1.21215693 |
| 50 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.20883033 |
| 51 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 1.19463428 |
| 52 | Carbon metabolism_Homo sapiens_hsa01200 | 1.17193232 |
| 53 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.16811829 |
| 54 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.16472150 |
| 55 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.15411129 |
| 56 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.12338058 |
| 57 | Amoebiasis_Homo sapiens_hsa05146 | 1.11584550 |
| 58 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.10158153 |
| 59 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.09028228 |
| 60 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.05077648 |
| 61 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.03873299 |
| 62 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.01716685 |
| 63 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.01405590 |
| 64 | Lysine degradation_Homo sapiens_hsa00310 | 0.99656934 |
| 65 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.98944001 |
| 66 | Focal adhesion_Homo sapiens_hsa04510 | 0.98855036 |
| 67 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.98194758 |
| 68 | Phagosome_Homo sapiens_hsa04145 | 0.96178898 |
| 69 | Melanoma_Homo sapiens_hsa05218 | 0.94801587 |
| 70 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.91565293 |
| 71 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.89897765 |
| 72 | Sulfur relay system_Homo sapiens_hsa04122 | 0.85372321 |
| 73 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.83332348 |
| 74 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.79394336 |
| 75 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.78412404 |
| 76 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.78352176 |
| 77 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.73827416 |
| 78 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.73019597 |
| 79 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.71397310 |
| 80 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.67259444 |
| 81 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.67107892 |
| 82 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.63923707 |
| 83 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.60227776 |
| 84 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.59494451 |
| 85 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.57443023 |
| 86 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.57094649 |
| 87 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.56804016 |
| 88 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.56648039 |
| 89 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.54757005 |
| 90 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.50034899 |
| 91 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.47699710 |
| 92 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.47584003 |
| 93 | Metabolic pathways_Homo sapiens_hsa01100 | 0.45890421 |
| 94 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.43779558 |
| 95 | Nicotine addiction_Homo sapiens_hsa05033 | 0.42740516 |
| 96 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.40167013 |
| 97 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.39833507 |
| 98 | Cocaine addiction_Homo sapiens_hsa05030 | 0.38140806 |
| 99 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.36998764 |
| 100 | Malaria_Homo sapiens_hsa05144 | 0.35172690 |
| 101 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.34994498 |
| 102 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.33686638 |
| 103 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.33599666 |
| 104 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.33041064 |
| 105 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.31493374 |
| 106 | Mineral absorption_Homo sapiens_hsa04978 | 0.31400248 |
| 107 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.30290586 |
| 108 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.30103037 |
| 109 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.28154170 |
| 110 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.27900626 |
| 111 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.22992909 |
| 112 | Insulin resistance_Homo sapiens_hsa04931 | 0.14235934 |
| 113 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.14143881 |
| 114 | Galactose metabolism_Homo sapiens_hsa00052 | 0.12501010 |
| 115 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.10098400 |
| 116 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.08590730 |
| 117 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.07388847 |
| 118 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.06320724 |
| 119 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.05887585 |
| 120 | Prion diseases_Homo sapiens_hsa05020 | 0.03301398 |
| 121 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.01995752 |
| 122 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.01152652 |
| 123 | Other glycan degradation_Homo sapiens_hsa00511 | 0.00183982 |
| 124 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | -0.1543159 |
| 125 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | -0.1536172 |
| 126 | Oxidative phosphorylation_Homo sapiens_hsa00190 | -0.1520995 |
| 127 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.1258884 |
| 128 | Hepatitis C_Homo sapiens_hsa05160 | -0.0938621 |
| 129 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.0672578 |
| 130 | Asthma_Homo sapiens_hsa05310 | -0.0635426 |
| 131 | AMPK signaling pathway_Homo sapiens_hsa04152 | -0.0462515 |
| 132 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0458257 |
| 133 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0349105 |

